FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

MA Russell

Research Profile

Chemicals & Drugs

Activities & Behaviors

Procedures

Disorders

Anatomy

Saliva

Concepts & Ideas

Living Beings

Co-author Network

Publications

TOP 3
John T Green; Brian K Evans; John Rhodes; G A O Thomas; C Ranshaw; Colin Feyerabend; MA Russell
An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics.
John A Stapleton; A Lowin; MA Russell
Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness.
John A Stapleton; MA Russell; Gay Sutherland; Colin Feyerabend
Nicotine availability from Eclipse tobacco-heating cigarette.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of MA Russell (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

1999: John T Green; Brian K Evans; John Rhodes; G A O Thomas; C Ranshaw; Colin Feyerabend; MA Russell
An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics.
British journal of clinical pharmacology 1999;48(4):485-93.
1999: John A Stapleton; A Lowin; MA Russell
Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness.
Lancet 1999;354(9174):210-5.
1998: John A Stapleton; MA Russell; Gay Sutherland; Colin Feyerabend
Nicotine availability from Eclipse tobacco-heating cigarette.
Psychopharmacology 1998;139(3):288-90.
1998: Jonathan Foulds; MA Russell; Martin J Jarvis; Colin Feyerabend
Nicotine absorption and dependence in unlicensed lozenges available over the counter.
Addiction (Abingdon, England) 1998;93(9):1427-31.
1998: John T Green; John Rhodes; Krish Ragunath; G A O Thomas; Geraint T Williams; V Mani; Colin Feyerabend; MA Russell
Clinical status of ulcerative colitis in patients who smoke.
The American journal of gastroenterology 1998;93(9):1463-7.
1998: John T Green; John Rhodes; G A O Thomas; Brian K Evans; Colin Feyerabend; MA Russell; WJ Sandborn
Nicotine carbomer enemas--pharmacokinetics of a revised formulation.
Italian journal of gastroenterology and hepatology 1998;30(3):260-5.
1998: John A Stapleton; G Sutherland; MA Russell
How much does relapse after one year erode effectiveness of smoking cessation treatments? Long-term follow up of randomised trial of nicotine nasal spray.
BMJ (Clinical research ed.) 1998;316(7134):830-1.
1997: John T Green; G A O Thomas; John Rhodes; Geraint T Williams; Brian K Evans; MA Russell; Colin Feyerabend; P Rhodes; WJ Sandborn
Nicotine enemas for active ulcerative colitis--a pilot study.
Alimentary pharmacology & therapeutics 1997;11(5):859-63.
1997: Jonathan Foulds; John A Stapleton; N Bell; J Swettenham; Martin J Jarvis; MA Russell
Mood and physiological effects of subcutaneous nicotine in smokers and never-smokers.
Drug and alcohol dependence 1997;44(2-3):105-15.
1997: John T Green; G A O Thomas; John Rhodes; Brian K Evans; MA Russell; Colin Feyerabend; G S Fuller; Robert G Newcombe; WJ Sandborn
Pharmacokinetics of nicotine carbomer enemas: a new treatment modality for ulcerative colitis.
Clinical pharmacology and therapeutics 1997;61(3):340-8.
1997: G A O Thomas; R D Pullan; Freek J Zijlstra; B J Rankin; MA Russell; Colin Feyerabend; A Allen; John Rhodes
Effect of nicotine on large bowel mucus thickness, eicosanoids and faecal proteinase in ferrets.
European journal of gastroenterology & hepatology 1997;9(2):179-82.
1997: H Parry; S Cohen; J E Schlarb; D A Tyrrell; A Fisher; MA Russell; M J Jarvis
Smoking, alcohol consumption, and leukocyte counts.
American journal of clinical pathology 1997;107(1):64-7.
1996: Jonathan Foulds; J Stapleton; J Swettenham; N Bell; K McSorley; MA Russell
Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers.
Psychopharmacology 1996;127(1):31-8.
1996: G A O Thomas; John Rhodes; K Ragunath; V Mani; Geraint T Williams; Robert G Newcombe; MA Russell; Colin Feyerabend
Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis.
European journal of gastroenterology & hepatology 1996;8(8):769-76.
1995: G Sutherland; John A Stapleton; MA Russell; Colin Feyerabend
Naltrexone, smoking behaviour and cigarette withdrawal.
Psychopharmacology 1995;120(4):418-25.
1995: G A O Thomas; John Rhodes; V Mani; Geraint T Williams; Robert G Newcombe; MA Russell; Colin Feyerabend
Transdermal nicotine as maintenance therapy for ulcerative colitis.
The New England journal of medicine 1995;332(15):988-92.
1995: John A Stapleton; MA Russell; Colin Feyerabend; S M Wiseman; G Gustavsson; U Sawe; D Wiseman
Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice.
Addiction (Abingdon, England) 1995;90(1):31-42.
1994: Jonathan Foulds; A Bryant; J Stapleton; M J Jarvis; MA Russell
The stability of cotinine in unfrozen saliva mailed to the laboratory.
American journal of public health 1994;84(7):1182-3.
1994: Jonathan Foulds; K McSorley; J Sneddon; Colin Feyerabend; M J Jarvis; MA Russell
Effect of subcutaneous nicotine injections of EEG alpha frequency in non-smokers: a placebo-controlled pilot study.
Psychopharmacology 1994;115(1-2):163-6.
1994: R D Pullan; John Rhodes; S Ganesh; V Mani; J S Morris; Geraint T Williams; Robert G Newcombe; MA Russell; Colin Feyerabend; G A O Thomas
Transdermal nicotine for active ulcerative colitis.
The New England journal of medicine 1994;330(12):811-5.
1994: Freek J Zijlstra; E D Srivastava; M Rhodes; A P van Dijk; F Fogg; H J Samson; M Copeman; MA Russell; Colin Feyerabend; Geraint T Williams
Effect of nicotine on rectal mucus and mucosal eicosanoids.
Gut 1994;35(2):247-51.
1993: MA Russell; John A Stapleton; Colin Feyerabend; S M Wiseman; G Gustavsson; U Sawe; P Connor
Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches.
BMJ (Clinical research ed.) 1993;306(6888):1308-12.
1993: G Sutherland; MA Russell; John A Stapleton; Colin Feyerabend
Glycerol particle cigarettes: a less harmful option for chronic smokers.
Thorax 1993;48(4):385-7.
1993: Jonathan Foulds; J Stapleton; M Hayward; MA Russell; Colin Feyerabend; T Fleming; J Costello
Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. A placebo-controlled trial.
Archives of family medicine 1993;2(4):417-23.
1992: G Sutherland; John A Stapleton; MA Russell; M J Jarvis; P Hajek; M Belcher; Colin Feyerabend
Randomised controlled trial of nasal nicotine spray in smoking cessation.
Lancet 1992;340(8815):324-9.
1992: Jonathan Foulds; J Stapleton; Colin Feyerabend; C Vesey; M Jarvis; MA Russell
Effect of transdermal nicotine patches on cigarette smoking: a double blind crossover study.
Psychopharmacology 1992;106(3):421-7.
1992: G Sutherland; MA Russell; J Stapleton; Colin Feyerabend; O Ferno
Nasal nicotine spray: a rapid nicotine delivery system.
Psychopharmacology 1992;108(4):512-8.
1991: MA Russell
The future of nicotine replacement.
British journal of addiction 1991;86(5):653-8.
1991: M J Jarvis; Ann McNeill; A Bryant; MA Russell
Factors determining exposure to passive smoking in young adults living at home: quantitative analysis using saliva cotinine concentrations.
International journal of epidemiology 1991;20(1):126-31.
1991: E D Srivastava; MA Russell; Colin Feyerabend; J G Masterson; John Rhodes
Sensitivity and tolerance to nicotine in smokers and nonsmokers.
Psychopharmacology 1991;105(1):63-8.
1990: E D Srivastava; MA Russell; Colin Feyerabend; John Rhodes
Effect of ulcerative colitis and smoking on rectal blood flow.
Gut 1990;31(9):1021-4.
1990: MA Russell
The nicotine addiction trap: a 40-year sentence for four cigarettes.
British journal of addiction 1990;85(2):293-300.
1990: MA Russell; M J Jarvis; G Jones; Colin Feyerabend
Non-smokers show acute tolerance to subcutaneous nicotine.
Psychopharmacology 1990;102(1):56-8.
1989: Ann McNeill; M J Jarvis; John A Stapleton; MA Russell; J Richard Eiser; P Gammage; E M Gray
Prospective study of factors predicting uptake of smoking in adolescents.
Journal of epidemiology and community health 1989;43(1):72-8.
1989: P H Jackson; John A Stapleton; MA Russell; R J Merriman
Nicotine gum use and outcome in a general practitioner intervention against smoking.
Addictive behaviors 1989;14(3):335-41.
1988: M J Jarvis; MA Russell; N L Benowitz; Colin Feyerabend
Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure.
American journal of public health 1988;78(6):696-8.
1988: MA Russell; John A Stapleton; P Hajek; P H Jackson; M Belcher
District programme to reduce smoking: can sustained intervention by general practitioners affect prevalence?
Journal of epidemiology and community health 1988;42(2):111-5.
1987: Ann McNeill; M J Jarvis; R West; MA Russell; A Bryant
Saliva cotinine as an indicator of cigarette smoking in adolescents.
British journal of addiction 1987;82(12):1355-60.
1987: MA Russell; John A Stapleton; P H Jackson; P Hajek; M Belcher
District programme to reduce smoking: effect of clinic supported brief intervention by general practitioners.
British medical journal (Clinical research ed.) 1987;295(6608):1240-4.
1987: M J Jarvis; Ann McNeill; MA Russell; R J West; A Bryant; C Feyerabend
Passive smoking in adolescents: one-year stability of exposure in the home.
Lancet 1987;1(8545):1324-5.
1986: MA Russell; M J Jarvis; Colin Feyerabend; Y Saloojee
Reduction of tar, nicotine and carbon monoxide intake in low tar smokers.
Journal of epidemiology and community health 1986;40(1):80-5.
1985: M J Jarvis; MA Russell; C Feyerabend; J Richard Eiser; M Morgan; P Gammage; E M Gray
Passive exposure to tobacco smoke: saliva cotinine concentrations in a representative population sample of non-smoking schoolchildren.
British medical journal (Clinical research ed.) 1985;291(6500):927-9.
1982: S R Sutton; MA Russell; R Iyer; Colin Feyerabend; Y Saloojee
Relationship between cigarette yields, puffing patterns, and smoke intake: evidence for tar compensation?
British medical journal (Clinical research ed.) 1982;285(6342):600-3.
1982: Y Saloojee; C J Vesey; P V Cole; MA Russell
Carboxyhaemoglobin and plasma thiocyanate: complementary indicators of smoking behaviour?
Thorax 1982;37(7):521-5.
1982: MA Russell; S R Sutton; R Iyer; Colin Feyerabend; C J Vesey
Long-term switching to low-tar low-nicotine cigarettes.
British journal of addiction 1982;77(2):145-58.
1982: C J Vesey; Y Saloojee; P V Cole; MA Russell
Blood carboxyhaemoglobin, plasma thiocyanate, and cigarette consumption: implications for epidemiological studies in smokers.
British medical journal (Clinical research ed.) 1982;284(6328):1516-8.
1980: M J Jarvis; MA Russell; Y Saloojee
Expired air carbon monoxide: a simple breath test of tobacco smoke intake.
British medical journal 1980;281(6238):484-5.
1980: MA Russell; M Jarvis; R Iyer; Colin Feyerabend
Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers.
British medical journal 1980;280(6219):972-6.
1980: MA Russell; S R Sutton; C Feyerabend; Y Saloojee
Smokers' response to shortened cigarettes: dose reduction without dilution of tobacco smoke.
Clinical pharmacology and therapeutics 1980;27(2):210-8.